Skip to main content
Premium Trial:

Request an Annual Quote

Applied Biosystems, NextGen Sciences, Genomic Solutions


Applied Biosystems recently introduced its 4800 MALDI TOF/TOF Analyzer, the newest in its TOF/TOF line of mass spectrometers.

According to the company, the new mass spec offers a ten-fold increase in sensitivity over previous systems. It combines Applied Biosystems/MDS Sciex joint venture's TOF/TOF optics technology with the novel OptiBeam on-axis laser, which increases the number of ions directed into the ion path.

NextGen Sciences announced this week the launch of its high-efficiency Escherichia coli strains, presented in 96-well plates. Each plate has a unique barcode that makes it easy to inventory the cells within the company's orchestratorIMS database. The orchestratorIMS information management system integrates gene manipulation software and a sample and reagents tracking database with robotic platforms for automated gene cloning and protein expression.

Genomic Solutions announced this week the launch of its Investigator ProPicII instrument for automated picking of spots from 2D gels. The instrument is able to simultaneously image, analyze and pick from two large-format 2D gels at the same time. Its CCD camera uses 16-bit technology and offers a resolution of 80 microns. The unit measures 35 inches in width.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.